UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934

For the Month of January 2017

333-206723
(Commission File Number)

P.V. Nano Cell Ltd.

(Exact name of Registrant as specified in its charter)

8 Hamasger Street
Migdal Ha’Emek, Israel 2310102

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover
Form 20-F or Form 40-F.

Form 20-F þ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): ____

 

 

  
 

On January 23, 2017, P.V. Nano Cell Ltd. (the “Issuer”) issued a press release announcing that the Depository Trust Company (DTC) has approved the Issuer’s eligibility application for its shares on the OTC. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 2 
 

 

Exhibit Index

Exhibit No.   Description
     
99.1   Press Release, dated January 23, 2017

 

 3 
 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  P.V. Nano Cell Ltd.
   
Date:  January 23, 2017 By:  /s/ Fernando de la Vega
    Name: Dr. Fernando de la Vega
Title: Chief Executive Officer

 

 4